Patheon Shareholders Sue To Stop $7.2B Thermo Fisher Deal
Patheon NV's proposed $7.2 billion acquisition by Thermo Fisher leaves investors out to dry, they alleged Monday in a proposed class action in New York federal court accusing the company and...To view the full article, register now.
Already a subscriber? Click here to view full article